The IMID Forum

Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions

26 Mar 2026

Contributed by Lukas

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review...

Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers

19 Mar 2026

Contributed by Lukas

Join Dr Sofia Ramiro and Dr Atul Dheodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the impact ...

Author Interview: Doctor Carlo Tur, February 2026

12 Mar 2026

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor Carlo Tur, from the department of Medicine 3-Rheumatology and Immunolog...

Author Interview - Professor Andrew Cope, 2026

05 Mar 2026

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrew Cope from the Centre for Rheumatic Diseases, King’s College...

Discussing RA: Pain outcomes and drug effectiveness of JAK inhibitors in RA and PsA

27 Feb 2026

Contributed by Lukas

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review...

Discussing PsA: Risankizumab efficacy across machine learning defined and complex PsA phenotypes

13 Feb 2026

Contributed by Lukas

Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘cl...

Author Interview: Professor Matthew Brown, 2026

03 Feb 2026

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Matthew Brown, the Chief Scientific Officer at Genomics England, as ...

Discussing RA: Long-term effectiveness and sex differences of JAK inhibitors in rheumatoid arthritis

29 Jan 2026

Contributed by Lukas

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review...

Discussing RA: UPA outcomes and the impact of GCs on targeted therapies in RA

18 Dec 2025

Contributed by Lukas

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he and Doctor ...

Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab

11 Dec 2025

Contributed by Lukas

Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered...

Discussing PsA: Uveitis risk and treatment sequencing outcomes in axSpa and PsA

04 Dec 2025

Contributed by Lukas

Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘th...

Discussing RA: Real-world evaluation of JAKi efficacy, persistence, and cardiovascular safety in RA

27 Nov 2025

Contributed by Lukas

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review...

Author Interview: Professor Filip Rob, 2025

20 Nov 2025

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Filip Rob, the Department of head of the Dermatovenereology at the S...

Webinar Highlights: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs: Part 2

16 Nov 2025

Contributed by Lukas

Webinar highlights! Join Professor Iain McInnes and Drs Grace Wright and Melinda Gooderham as they discuss advancing patient care through an interdisc...

Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis

13 Nov 2025

Contributed by Lukas

Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered...

Discussing RA: Long-term management of elderly patients with RA treated with tocilizumab

06 Nov 2025

Contributed by Lukas

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, Iain will revi...

ACR 2025 Review Podcast

05 Nov 2025

Contributed by Lukas

Join Doctor Sofia Ramiro and Professors Janet Pope and Atul Deodhar, as they review and discuss key data from ACR 2025 across RA, PsA, and axSpA, focu...

ACR Daily Highlights Day 4

29 Oct 2025

Contributed by Lukas

Join Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 4 of ACR 2025 (Wednesdsy, 29th of October)

ACR Daily Highlights: Day 3

28 Oct 2025

Contributed by Lukas

Join Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 3 of ACR 2025 (Tuesday 28th of October)

Pathways Modulating IMIDs: Webinar Highlights Podcast

28 Oct 2025

Contributed by Lukas

Professors Janet Pope and John Isaacs discuss all the highlights from the 'Pathways Modulating IMIDs' webinar.

ACR Daily Highlights: Day 2

27 Oct 2025

Contributed by Lukas

Join Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 2 of ACR 2025 (Monday, 27th of October)

ACR Daily Highlights: Day 1

26 Oct 2025

Contributed by Lukas

Join Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 1 of ACR 2025 (Sunday, 26th of October)

ACR 2025 Preview Podcast

22 Oct 2025

Contributed by Lukas

Join Professors Peter Nash, Janet Pope and Atul Deodhar as they preview what they are most looking forward to this ACR, introducing some of the top ch...

Discussing PsA: Comparative effectiveness of biologic and targeted therapies in PsA: Insights from PARWCH and KEEPsAKE studies

09 Oct 2025

Contributed by Lukas

Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘th...

Author Interview: Doctor David Kellner, September 2025

02 Oct 2025

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor David Kellner, an IGNITE-MSCR Fellow of the Division of Rheumatology, f...

Discussing RA: Safety and vaccine immunogenicity of upadacitinib across immune-mediated diseases

25 Sep 2025

Contributed by Lukas

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he highlights ...

Discussing axSpA: Comparative real-world effectiveness of biologic and targeted therapies in axSpA

18 Sep 2025

Contributed by Lukas

Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered...

Discussing RA: Efficacy and safety of upadacitinib for patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis

04 Sep 2025

Contributed by Lukas

Join Professor Iain McInnes as he discusses the top publications in the world of RA. This month’s discussion covered the ‘Efficacy and safety of u...

Author Interview: Doctor Rodrigo Garcia‑Salinas, August 2025

28 Aug 2025

Contributed by Lukas

Join Professor Peter Nash from Griffith University in Brisbane, and Dr Rodrigo Garcia‑Salinas from Hospital Italiano de La Plata in Argentina, as th...

Author Interview: Doctor Martin Schaefer and Professor Anja Strangfeld, July 2025

14 Aug 2025

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and authors Dr Martin Schaefer from the German Rheumatology Research Center in Ber...

Discussing PsA: Post hoc analyses on secukinumab and deucravacitinib from Phase 2 and 3 trials

07 Aug 2025

Contributed by Lukas

Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘th...

Discussing RA: Comparative outcomes of JAK inhibition and TNF blockade vs dual JAK–ROCK targeting

31 Jul 2025

Contributed by Lukas

Join Professor Iain McInnes as he discusses the top publications in the world of RA. This month, the conversation covered the ‘dual JAK and ROCK inh...

Discussing axSpA: Secukinumab treatment outcomes on sustained remission and skeletal health in axSpA

10 Jul 2025

Contributed by Lukas

Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered...

Difficult-to-treat disease in Rheumatology Podcast Professors Iain McInnes and Peter Nash

03 Jul 2025

Contributed by Lukas

Join Professor Iain McInnes from the University of Glasgow, and Professor Peter Nash from the Griffith University in Brisbane, as they discuss the con...

EULAR 2025 Review Podcast

02 Jul 2025

Contributed by Lukas

Join Professors Xenofon Baraliakos, Laura Coates, and Johannes Bijlsma as they review their highlights of the recent EULAR 2025 congress, and watch th...

Discussing RA: Impact of TOF on BMI, UPA monotherapy in MTX-IRs, and JAKis vs TNFis treatment

26 Jun 2025

Contributed by Lukas

Join Professor Iain McInnes and Professor Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the...

EULAR 2025 Highlights: Day 4

14 Jun 2025

Contributed by Lukas

Join Professor Xenofon Baraliakos as he summarises his top abstracts, posters, and presentations from Day 4 of EULAR 2025 (Saturday, June 14).

EULAR 2025 Highlights: Day 3

13 Jun 2025

Contributed by Lukas

Join Professor Xenofon Baraliakos as he summarises his top abstracts, posters, and presentations from Day 3 of EULAR 2025 (Friday, June 13).

Discussing PsA: Real-world data on biologic switching and the development of EMMs

12 Jun 2025

Contributed by Lukas

Join Professors Philip Mease and Laura Coates and as they discuss the top publications in the world of PsA. This month, the conversation covered a dis...

EULAR 2025 Highlights: Day 2

12 Jun 2025

Contributed by Lukas

Join Professor Xenofon Baraliakos as he summarises his top abstracts, posters, and presentations from Day 2 of EULAR 2025 (Thursday, June 12).

EULAR 2025 Highlights: Day 1

11 Jun 2025

Contributed by Lukas

Join Professor Xenofon Baraliakos as he summarises his top abstracts, posters, and presentations from Day 1 of EULAR 2025 (Wednesday, June 11).

EULAR 2025 Preview Podcast

09 Jun 2025

Contributed by Lukas

Join Professors Xenofon Baraliakos, Laura Coates, and Johannes Bijlsma as they guide you through what they are most looking forward to in RA, PsA, and...

Discussing RA: MACE in RA, data from the "JAK-pot" study, and combination therapy in MTX-IR RA

05 Jun 2025

Contributed by Lukas

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. I...

Podcast: AuToDeCRA, June 2025

04 Jun 2025

Contributed by Lukas

Join Professor Ian McInnes from the University of Glasgow, and Professors John Isaacs and Andrew Cope, as they discuss the latest AuToDeCRA study and ...

Webinar Highlights Podcast: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs

28 May 2025

Contributed by Lukas

Join Professor Herve Bachelez and Professors Iain McInnes and Tim Orchard as they discuss the recent webinar hosted on the IMID Forum: “Advancing Pa...

Author Interview: Dr Saqr Alsakarneh, May 2025

22 May 2025

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Saqr Alsakarneh, Internal Medicine Resident at University of Missouri–Kan...

Discussing axSpA: JAKi cycling and long-term safety of bimekizumab in patients with axSpA or PsA

08 May 2025

Contributed by Lukas

Join Dr Sofia Ramiro and cohosts Professors Atul Deodhar, Hideto Kameda, and Xenofon Baraliakos for the latest episode of the discussing axSpA podcast...

Discussing RA: MACE, VTE, and malignancy in filgotinib RA and UC patients, and MACE related to JAKis

01 May 2025

Contributed by Lukas

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. ...

Highlights Podcast: IL-17 Inhibition: Controlling inflammation and disease progression in SpA

16 Apr 2025

Contributed by Lukas

Highlights Podcast: IL-17 Inhibition: Controlling inflammation and disease progression in SpA by The Immune-Mediated Inflammatory Disease Forum

Discussing PsA: JAKi Comparative safety & Burden and determinants of multi‑b/tsDMARD failure in PsA

03 Apr 2025

Contributed by Lukas

Join Professors Laura Coates and Philip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered a discuss...

Discussing RA: Pain reduction & choosing second-line DMARDs after unresponsive first-line DMARDs

27 Mar 2025

Contributed by Lukas

Join Professors Iain McInnes and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest up...

Author Interview: Professor Phillip Helliwell, March 2025

20 Mar 2025

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Phillip Helliwell, Professor of rheumatology at The University of Le...

Author Interview: Professor Phillip Helliwell, 2025

13 Mar 2025

Contributed by Lukas

Author Interview: Professor Phillip Helliwell, 2025 by The Immune-Mediated Inflammatory Disease Forum

Discussing PsA: Bimekizumab improves patient-reported outcomes and work productivity

06 Mar 2025

Contributed by Lukas

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, the conversation cove...

Discussing axSpA: Long-term safety and efficacy of Bimekizumab results from BE-AGILE & BE-MOBILE 1/2

27 Feb 2025

Contributed by Lukas

Join Dr Sofia Ramiro and cohosts Professors Atul Deodhar, Hideto Kameda, and Xenofon Baraliakos for the latest episode of the discussing axSpA podcast...

Discussing RA: Baricitinib dose reduction and switching to bDMARDs vs JAKis

27 Feb 2025

Contributed by Lukas

Join Professors Iain McInnes, Hans Bijlsma, and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discus...

Author Interview: Professor Denis McGonagle, 2025

06 Feb 2025

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Denis McGonagle, Professor of investigative rheumatology at the NIHR...

Discussing RA: Insights into sustained DMARD-free remission and barriers to CAR T-cell therapy

23 Jan 2025

Contributed by Lukas

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. I...

Discussing RA: Insights into Filgotinib and Tofacitinib in RA

19 Dec 2024

Contributed by Lukas

Join Professor Iain McInnes and Professor Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the...

Discussing AxSpA Podcast: Efficacy and Safety of Upadacitinib

19 Dec 2024

Contributed by Lukas

Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Profes...

Discussing PsA: DISCOVER-2 and BE OPTIMAL/BE COMPLETE post-hoc analyses

28 Nov 2024

Contributed by Lukas

Join Professors Peter Nash and Philip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered a post hoc ...

ACR 2024 Review Podcast

28 Nov 2024

Contributed by Lukas

ACR 2024 Review Podcast by The Immune-Mediated Inflammatory Disease Forum

Discussing RA: Insights into Filgotinib and Tofacitinib in RA

14 Nov 2024

Contributed by Lukas

Join Professor Iain McInnes and Professor Johannes Bijlsma for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discus...

Webinar Highlights Podcast: CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases

13 Nov 2024

Contributed by Lukas

Webinar Highlights Podcast: Join Professor Iain McInnes and Professor Georg Schett as they discuss the recent webinar hosted on the IMID Forum: “CAR...

ACR 2024 Highlights: Day 1

11 Nov 2024

Contributed by Lukas

ACR 2024 Highlights: Day 1 by The Immune-Mediated Inflammatory Disease Forum

ACR 2024: Preview Podcast

11 Nov 2024

Contributed by Lukas

ACR 2024: Preview Podcast by The Immune-Mediated Inflammatory Disease Forum

ACR 2024 Highlights: Day 3

11 Nov 2024

Contributed by Lukas

ACR 2024 Highlights: Day 3 by The Immune-Mediated Inflammatory Disease Forum

ACR 2024 Highlights: Day 2

11 Nov 2024

Contributed by Lukas

ACR 2024 Highlights: Day 2 by The Immune-Mediated Inflammatory Disease Forum

AxSpA Podcast: Efficacy and Safety of IV secukinumab

31 Oct 2024

Contributed by Lukas

Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Profes...

Discussing RA: Navigating JAKis, TNFis, and the quest for optimal RA therapy

31 Oct 2024

Contributed by Lukas

Join Professor Iain McInnes and Professor Leonard Calabrese for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discu...

Author Interview: Derin Karacabeyli, 2024

10 Oct 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Derin Karacabeyli of Arthritis Research Canada, a rheumatologist and reside...

Webinar Highlights Podcast 2: Evolving Therapeutic Strategies for Psoriatic Diseases

07 Oct 2024

Contributed by Lukas

Webinar Highlights Podcast: Join Professor Christopher Ritchlin, and Professor Philip Mease as they discuss the recent webinar hosted on the IMID Foru...

PsA Podcast: Bimekizumab: Efficacy, safety, and effectiveness in PsA

26 Sep 2024

Contributed by Lukas

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, the conversation cove...

Discussing RA: Long-term safety and efficacy of upadacitinib in SELECT trials

19 Sep 2024

Contributed by Lukas

Join Professor Iain McInnes and Professors Hideto Kameda and Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, whe...

Discussing AxSpA: Incidence of uveitis following bimekizumab treatment

29 Aug 2024

Contributed by Lukas

Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Profes...

Author Interview: Professor Laura Andreoli, 2024

22 Aug 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Laura Andreoli, a Professor of Rheumatology at the University of Bre...

Discussing RA: Neutrophil-to-lymphocyte ratio and treatment response to filgotinib

15 Aug 2024

Contributed by Lukas

Join Professor Iain McInnes and Professors Hideto Kameda and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, wher...

Discussing PsA: Guselkumab and analysis of genetic markers

12 Aug 2024

Contributed by Lukas

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, the conversation cove...

Discussing AxSpA: Upadacitinib in nr-axSpA and certolizumab pegol by baseline MRI and CRP status

12 Aug 2024

Contributed by Lukas

Join us for the latest axSpA podcast brought to you by the Immune- ediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Profes...

Discussing PsA: Bimekizumab therapy in PsA

12 Aug 2024

Contributed by Lukas

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the lat...

IMID Author Interview: Dr Blanca Hernández-Cruz, 2024

12 Aug 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Blanca Hernández-Cruz, a rheumatologist at Virgen Macarena University Hospita...

Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab

12 Aug 2024

Contributed by Lukas

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month, Dr Sofia Ramiro is joined by Profes...

Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib

12 Aug 2024

Contributed by Lukas

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the upd...

Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs

12 Aug 2024

Contributed by Lukas

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Profess...

Discussing PsA: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population

12 Aug 2024

Contributed by Lukas

Join Professors Peter Nash, Philip Mease, Frank Behrens, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two h...

Discussing RA: March 2024

12 Aug 2024

Contributed by Lukas

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and da...

Discussing AxSpA: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment

12 Aug 2024

Contributed by Lukas

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Profess...

Discussing RA: February 2024

12 Aug 2024

Contributed by Lukas

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and da...

Discussing PsA: Clinical Response to Guselkumab & Sequential Lines of b/tsDMARDs

12 Aug 2024

Contributed by Lukas

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant ...

Discussing RA: January 2024

12 Aug 2024

Contributed by Lukas

Join Professor Iain McInnes for the first episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and dat...

Discussing AxSpA: Long-Term Outcomes of Secukinumab & JAKis in Clinical Practice

12 Aug 2024

Contributed by Lukas

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Profess...

Discussing PsA: Secukinumab & The Effect of Sex on the Long-Term Persistence of Targeted Therapies

12 Aug 2024

Contributed by Lukas

Join Professors Peter Nash, Philip Mease, Frank Behrens, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two h...

Discussing AxSpA: Bimekizumab in AxSpA & Secukinumab Patient Clustering

12 Aug 2024

Contributed by Lukas

Join us for the latest axSpA podcast brought to you by the CSF! This month Dr Sofia Ramiro, consultant rheumatologist and senior researcher at Leiden ...

Author Interview: Dr Adam Goldman, 2024

08 Aug 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Adam Goldman, an epidemiology researcher at The Chaim Sheba Medical Center ...

Author Interview: Professor Daniel Blockmans, 2024

25 Jul 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Daniel Blockmans, from the Department of Internal Medicine at the Un...

Discussing RA: July 2024

18 Jul 2024

Contributed by Lukas

Join Professor Iain McInnes and guest Professor Maurizio Cutolo for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they d...

Discussing RA: June 2024

27 Jun 2024

Contributed by Lukas

Join Professors Iain McInnes, Peter Nash, and Maurizio Cutolo for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they dis...

EULAR 2024 Review Podcast

19 Jun 2024

Contributed by Lukas

Join Dr Sofia Ramiro, Professor Rieke Alten, and Associate Professor Laura Coates as they review their top sessions in RA, PsA, and axSpA from EULAR 2...

EULAR 2024 Highlights: Day 4

15 Jun 2024

Contributed by Lukas

Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 1 of EULAR 2024 (Saturday, June 15).

EULAR 2024 Highlights: Day 3

14 Jun 2024

Contributed by Lukas

Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 3 of EULAR 2024 (Friday, June 14).